Prevention of Secondary Stroke in Individuals with Atrial Fibrillation: Interventions and Studies

Atrial fibrillation, a prevalent cardiac arrhythmia, significantly contributes to ischemic stroke risk. Recent research highlights the importance of atrial fibrillation burden and its association with stroke recurrence. Secondary prevention aims to reduce this risk in atrial fibrillation stroke patients. Early initiation of direct oral anticoagulant medication (within 48-5 days for severe strokes) may lower early recurrence risk. Other promising strategies include early rhythm control, left atrial appendage closure, and new factor XI inhibitor oral anticoagulants. Despite the availability of oral anticoagulants, there’s an unmet medical need for secondary preventive techniques in atrial fibrillation stroke patients. Current research explores novel strategies, suggesting diverse factors influencing stroke prevention. Recent randomized controlled trials indicate oral anticoagulation lowers the risk of ischemic stroke in patients with atrial fibrillation and a history of intracerebral hemorrhage, but further evidence is required to assess safety